Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Intangibles (2018)

Neuroone Medical Technologies posted quarterly Change in Intangibles of $146709.0 for Q2 2018, up 59.97% on a QoQ basis from $91709.0 in Q1 2018.

Neuroone Medical Technologies (NMTC) has 1 years of Change in Intangibles data on file, last reported at $146709.0 in Q2 2018.

  • For the quarter ending Q2 2018, Change in Intangibles changed N/A year-over-year to $146709.0; the trailing twelve-month figure through Sep 2019 stood at $238418.0 (changed N/A YoY), and the FY2019 full-year result was $65000.0, up 18.18% from the prior year.
  • Change in Intangibles for Q2 2018 stood at $146709.0, up from $91709.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $146709.0 in Q2 2018 and bottomed at $91709.0 in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -31.61 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Neuroone Medical Technologies 31.39 Mn 28.59 Mn 1.29 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2018 146,709.00
Jun 30, 2018 146,709.00
Mar 31, 2018 91,709.00
Mar 31, 2018 91,709.00